QuidelOrtho Corp. QDEL

What this company does

QuidelOrtho sells its products directly to end users through a direct sales force and through a network of distributors, for use in settings that include physician offices, hospitals, clinical and reference laboratories, urgent care clinics, and blood banks and donor centers, as well as for individual, non-professional, over-the-counter use. As of December 28, 2025, the company had approximately 6,500 employees worldwide, with approximately 3,600 employees in the United States and approximately 2,900 employees outside the United States. For the fiscal year ended 2025, one customer represented 11% of the company's total revenues. Its primary manufacturing facilities are located in Carlsbad, California; San Diego, California; Athens, Ohio; Raritan, New Jersey; Rochester, New York; Pompano Beach, Florida; and Pencoed, Wales, with an additional manufacturing facility in Changsha, China. The company generates its revenue across four business units: Labs, Transfusion Medicine, Point of Care and Molecular Diagnostics. The Transfusion Medicine business unit includes two product categories: Immunohematology instruments and tests used for blood typing and antibody identification, and Donor Screening instruments and tests used for blood and plasma screening for infectious diseases.

Written from the business description in QuidelOrtho Corp's annual report to the U.S. Securities and Exchange Commission, filed 19 February 2026. Every sentence was checked against that document before publication.